Advertisement

Index by author

January 01, 2023; Volume 384,Issue 1

  1. Abd Elmageed, Zakaria Y.

    1. Circulating microRNAs as Reliable Tumor Biomarkers: Opportunities and Challenges Facing Clinical Application
      Sherien M. El-Daly, Shaimaa A. Gouhar and Zakaria Y. Abd Elmageed
      Journal of Pharmacology and Experimental Therapeutics January 2023, 384 (1) 35-51; DOI: https://doi.org/10.1124/jpet.121.000896

  2. Ai, Kai

    1. Open Access
      CircRNA_33702 Promotes Renal Fibrosis by Targeting the miR-29b-3p/WNT1-Inducible Signaling Pathway Protein 1 Pathway
      Kai Ai, Lei Yi, Yinhuai Wang and Yuan Li
      Journal of Pharmacology and Experimental Therapeutics January 2023, 384 (1) 61-71; DOI: https://doi.org/10.1124/jpet.122.001280

  3. Akaike, Norio

    1. Depression of Synaptic N-methyl-D-Aspartate Responses by Xenon and Nitrous Oxide
      Naoki Kotani, Il-Sung Jang, Michiko Nakamura, Kiku Nonaka, Hideaki Nagami and Norio Akaike
      Journal of Pharmacology and Experimental Therapeutics January 2023, 384 (1) 187-196; DOI: https://doi.org/10.1124/jpet.122.001346

  4. Arici, Martina

    1. Istaroxime Metabolite PST3093 Selectively Stimulates SERCA2a and Reverses Disease-Induced Changes in Cardiac Function
      Open Access
      Istaroxime Metabolite PST3093 Selectively Stimulates SERCA2a and Reverses Disease-Induced Changes in Cardiac Function
      Martina Arici, Mara Ferrandi, Paolo Barassi, Shih-Che Hsu, Eleonora Torre, Andrea Luraghi, Carlotta Ronchi, Gwo-Jyh Chang, Francesco Peri, Patrizia Ferrari, Giuseppe Bianchi, Marcella Rocchetti and Antonio Zaza
      Journal of Pharmacology and Experimental Therapeutics January 2023, 384 (1) 231-244; DOI: https://doi.org/10.1124/jpet.122.001335

  5. Avvisato, Roberta

    1. Mitochondrial microRNAs Are Dysregulated in Patients with Fabry Disease
      Jessica Gambardella, Antonella Fiordelisi, Daniela Sorriento, Federica Cerasuolo, Antonietta Buonaiuto, Roberta Avvisato, Antonio Pisani, Fahimeh Varzideh, Eleonora Riccio, Gaetano Santulli and Guido Iaccarino
      Journal of Pharmacology and Experimental Therapeutics January 2023, 384 (1) 72-78; DOI: https://doi.org/10.1124/jpet.122.001250
    2. Istaroxime and Beyond: New Therapeutic Strategies to Specifically Activate SERCA and Treat Heart Failure
      Roberta Avvisato, Stanislovas S. Jankauskas and Gaetano Santulli
      Journal of Pharmacology and Experimental Therapeutics January 2023, 384 (1) 227-230; DOI: https://doi.org/10.1124/jpet.122.001446

  6. Banks, William A.

    1. Transport of the Proinflammatory Chemokines C-C Motif Chemokine Ligand 2 (MCP-1) and C-C Motif Chemokine Ligand 5 (RANTES) across the Intact Mouse Blood-Brain Barrier Is Inhibited by Heparin and Eprodisate and Increased with Systemic Inflammation
      Daniel V. Quaranta, Riley R. Weaver, Kristen K. Baumann, Takashi Fujimoto, Lindsey M. Williams, Hyung Chan Kim, Aric F. Logsdon, Mohamed Omer, May J. Reed, William A. Banks and Michelle A. Erickson
      Journal of Pharmacology and Experimental Therapeutics January 2023, 384 (1) 205-223; DOI: https://doi.org/10.1124/jpet.122.001380

  7. Barassi, Paolo

    1. Istaroxime Metabolite PST3093 Selectively Stimulates SERCA2a and Reverses Disease-Induced Changes in Cardiac Function
      Open Access
      Istaroxime Metabolite PST3093 Selectively Stimulates SERCA2a and Reverses Disease-Induced Changes in Cardiac Function
      Martina Arici, Mara Ferrandi, Paolo Barassi, Shih-Che Hsu, Eleonora Torre, Andrea Luraghi, Carlotta Ronchi, Gwo-Jyh Chang, Francesco Peri, Patrizia Ferrari, Giuseppe Bianchi, Marcella Rocchetti and Antonio Zaza
      Journal of Pharmacology and Experimental Therapeutics January 2023, 384 (1) 231-244; DOI: https://doi.org/10.1124/jpet.122.001335

  8. Barf, Tjeerd

    1. Open Access
      Identification and Characterization of ACP-5862, the Major Circulating Active Metabolite of Acalabrutinib: Both Are Potent and Selective Covalent Bruton Tyrosine Kinase Inhibitors 
      Terry Podoll, Paul G. Pearson, Allard Kaptein, Jerry Evarts, Gerjan de Bruin, Maaike Emmelot-van Hoek, Anouk de Jong, Bart van Lith, Hao Sun, Stephen Byard, Adrian Fretland, Niels Hoogenboom, Tjeerd Barf and J. Greg Slatter
      Journal of Pharmacology and Experimental Therapeutics January 2023, 384 (1) 173-186; DOI: https://doi.org/10.1124/jpet.122.001116

  9. Baumann, Kristen K.

    1. Transport of the Proinflammatory Chemokines C-C Motif Chemokine Ligand 2 (MCP-1) and C-C Motif Chemokine Ligand 5 (RANTES) across the Intact Mouse Blood-Brain Barrier Is Inhibited by Heparin and Eprodisate and Increased with Systemic Inflammation
      Daniel V. Quaranta, Riley R. Weaver, Kristen K. Baumann, Takashi Fujimoto, Lindsey M. Williams, Hyung Chan Kim, Aric F. Logsdon, Mohamed Omer, May J. Reed, William A. Banks and Michelle A. Erickson
      Journal of Pharmacology and Experimental Therapeutics January 2023, 384 (1) 205-223; DOI: https://doi.org/10.1124/jpet.122.001380

  10. Becker, Andreas D.

    1. Open Access
      Translational PK/PD Modeling of Tumor Growth Inhibition and Target Inhibition to Support Dose Range Selection of the LMP7 Inhibitor M3258 in Relapsed/Refractory Multiple Myeloma
      Floriane Lignet, Christina Esdar, Gina Walter-Bausch, Manja Friese-Hamim, Sofia Stinchi, Elise Drouin, Samer El Bawab, Andreas D. Becker, Claude Gimmi, Michael P. Sanderson and Felix Rohdich
      Journal of Pharmacology and Experimental Therapeutics January 2023, 384 (1) 163-172; DOI: https://doi.org/10.1124/jpet.122.001355
« Previous (Pages : 1 2 3 4 5 6 ... 16) Next »
Back to top

In this issue

Advertisement